oxidopamine has been researched along with Goldblatt Syndrome in 4 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurnjek, ML | 2 |
| Basso, N | 2 |
| Taquini, AC | 2 |
| Ruiz, P | 1 |
| Nakada, T | 2 |
| Koike, H | 2 |
| Katayama, T | 2 |
4 other studies available for oxidopamine and Goldblatt Syndrome
| Article | Year |
|---|---|
Neonatal 6-hydroxydopamine treatment and the development of renal hypertension in the rat.
Topics: Animals; Blood Pressure; Brain; Hydroxydopamines; Hypertension, Renovascular; Male; Norepinephrine; | 1984 |
Effect of central norepinephrine depletion on renovascular hypertension and on the renin system.
Topics: Angiotensinogen; Animals; Blood Pressure; Brain; Hypertension, Renovascular; Male; Norepinephrine; O | 1993 |
Central noradrenergic neurons and vascular non-collagen protein in the initial phase of two-kidney, one-clip renovascular hypertension.
Topics: Animals; Aorta; Blood Pressure; Blood Vessels; Body Weight; Catecholamines; Dopamine; Hexamethonium; | 1988 |
Participation of central norepinephrine in the development of two-kidney, one clip Goldblatt hypertension.
Topics: Animals; Blood Pressure; Dopamine; Hydroxydopamines; Hypertension, Renovascular; Hypothalamus; Injec | 1986 |